During the event in Riyadh, CEO Stefan Savic highlighted how science, technology, and capital are driving the rapidly growing Longevity Economy.
Forbes Czechia has published an in depth interview with Michal Zahradnicek, founder of Primecell and co founder of LIFE BioCEED. The article explores how two decades of work in regenerative medicine and technology transfer are shaping the future of longevity and advanced therapies in Central and Eastern Europe.
LIFE BioCEEd’s investment supports the development of a non-invasive, highly sensitive blood test for multiple myeloma, aiming to replace painful bone marrow procedures and improve early disease detection.
Bridging Science and Investment: LIFE BioCEEd Partners with Wrocław University of Science and Technology
Exploring the untapped potential of Czech and regional science, LIFE BioCEED seeks to transform hidden discoveries into life-changing impact.
First investment targets groundbreaking treatment for Netherton syndrome
LIFE BioCEEd has signed a Memorandum of Cooperation with the Centre for Advanced Materials Application of the Slovak Academy of Sciences (CEMEA SAV, v.v.i.) to connect advanced materials research with biomedical innovation.
What once seemed like research destined to end in a drawer has turned into one of the largest biotech deals in recent years.
Protože tech transfer vytváří konkurenční výhody, vyšší přidanou hodnotu a tím bohatší národ.
Primecell, a biotechnology company owned by one of the founders of LIFE BioCEEd, has sold a majority stake in two biotechnology companies. These were acquired by VITA 34, the global leader in the field, based in Germany. The transaction, whose key value lies in its expertise in cell therapy, is one of the most significant in the Czech biotechnology sector in the last 20 years.
The partnership aims to accelerate the development and commercialization of academic healthcare and biotech innovations in Central Europe.
With CZK 500 million in backing and partnerships across CEE universities and research institutes, LIFE BioCEEd scouts, develops and commercializes breakthrough medical inventions.
Strategic MoU to support the development and commercialization of healthtech and biomedical innovations
LIFE BioCEEd and CTT MUG Enter Strategic Cooperation to Advance Biomedical Innovation
LIFE bioCEEd and University Hospital Hradec Králové Sign Memorandum of Cooperation to Accelerate the Transfer of Medical Innovations into Clinical Practice
